News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Agilent Revolutionizes HPLC with the Launch of the Agilent Infinity III LC Series
Monday, October 21, 2024Agilent Technologies Inc today announced the release of its next generation Agilent InfinityLab LC Series portfolio which includes the Infinity III LC Infinity III Prime LC and Infinity III LC systems all including the biocompatible versions These...
ARTHEx Biotech Announces First Patient Dosed in Phase I-IIa ArthemiR™ Trial for Myotonic Dystrophy Type 1 (DM1)
Friday, October 18, 2024ARTHEx Biotech SL a clinicalstage biotechnology company focused on developing innovative medicines through the modulation of gene expression announced today that the first participant has been dosed in the Randomized Placebo Controlled Double Blind P...
Nusano and Starget Pharma Announce Supply Agreement to Accelerate Smart Targeted Radioligand Development
Friday, October 18, 2024Nusano a physics company transforming the production of radioisotopes and Starget Pharma a clinicalstage biotechnology company developing precision peptide radioligand therapies focused on difficult to treat cancers today announced a supply agreement...
Valneva and LimmaTech Awarded FDA Fast Track Designation for Tetravalent Shigella Vaccine Candidate S4V
Thursday, October 17, 2024Valneva SE a specialty vaccine company and LimmaTech Biologics AG a clinicalstage biotech company developing vaccines for the prevention of lifethreatening diseases announced today that the US Food and Drug Administration FDA has granted Fast Track d...
Cellular Origins, Fresenius Kabi Sign Development Agreement for Scalable Automation of Cell and Gene Therapy Manufacturing
Thursday, October 17, 2024Cellular Origins and Fresenius Kabi an operating company of Fresenius announce today they have signed a development agreement that leverages each companys expertise in cell and gene therapies CGTsThe agreement is designed with the goal of digitally a...
Cytosurge and Lexogen Partner to Advance Live-Cell Sequencing
Wednesday, October 16, 2024Cytosurge AG a leader in singlecell manipulation and Lexogen a pioneer in RNA sequencing solutions have announced their partnership to advance livecell sequencing Liveseq The collaboration integrates Cytosurges FluidFM OMNIUM platform with Lexogens L...
Bioversys Announces Last Patient Last Visit in BV100 Phase 2 Clinical Trial in Ventilator Associated Bacterial Pneumonia (VABP) and Provides a Business Update
Wednesday, October 16, 2024BioVersys AG a multiasset clinical stage biopharmaceutical company focusing on research and development of novel antibacterial products for serious lifethreatening infections caused by multidrug resistant MDR bacteria announced today the completion o...
Fresenius and Cellular Origins announce development agreement for Cell and Gene Therapy Manufacturing
Wednesday, October 16, 2024Fresenius via its operating company Fresenius Kabi and Cellular Origins a TTP Company have entered an agreement to develop integration strategies for Fresenius Kabis portfolio of Cell Therapy Technologies within Cellular Origins Constellation automat...
Chiesi Group's new Biotech Center of Excellence brings the future of medicine to Parma, Italy
Tuesday, October 15, 2024Chiesi Group an international biopharmaceutical company focused on research celebrated the operational launch of its Biotech Center of Excellence This stateoftheart facility is dedicated to developing and producing monoclonal antibodies enzymes and o...
SystImmune, Inc. Announces FDA Clearance of IND Application for BL-M11D1 in Relapsed/Refractory Acute Myeloid Leukemia
Tuesday, October 15, 2024SystImmune Inc a clinicalstage biotechnology company announced that the US Food and Drug Administration FDA has cleared its Investigational New Drug IND application for BLMD an antibodydrug conjugate ADC binding CD a protein on myeloid cells The IND...
